Evidence map›Paper›PMID 30874603›Full record

ArticleScientific reports2019

Use of FCC-NMRD relaxometry for early detection and characterization of ex-vivo murine breast cancer.

Enza Di Gregorio, Giuseppe Ferrauto, Stefania Lanzardo, Eliana Gianolio, Silvio Aime

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Joint multi-field TMagnetic resonance in medicine · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Enza Di GregorioDepartment of Molecular Biotechnology and Health Sciences, Via Nizza 52, 10126, Torino, Italy.
Giuseppe FerrautoDepartment of Molecular Biotechnology and Health Sciences, Via Nizza 52, 10126, Torino, Italy.
Stefania LanzardoDepartment of Molecular Biotechnology and Health Sciences, Via Nizza 52, 10126, Torino, Italy.
Eliana GianolioDepartment of Molecular Biotechnology and Health Sciences, Via Nizza 52, 10126, Torino, Italy.
Silvio AimeDepartment of Molecular Biotechnology and Health Sciences, Via Nizza 52, 10126, Torino, Italy. silvio.aime@unito.it.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast Cancer is the most diffuse cancer among women and the treatment outcome is largely determined by its early detection. MRI at fixed magnetic field is already widely used for cancer detection. Herein it is shown that the acquisition of proton T

Indexed as

AnimalsBreast NeoplasmsContrast MediaEarly Detection of CancerFemaleMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMiceMice, Inbred BALB CMice, TransgenicProtonsContrast MediaProtons

Identifiers

PMID30874603
PMCPMC6420649
OpenAlexW2921775127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.